Skip to content

Ankle fracture fixation with or without a tourniquet

Tourniquet use in ankle fracture fixation surgery: a feasibility randomised controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN91783787
Enrollment
74
Registered
2025-05-14
Start date
2025-07-07
Completion date
Unknown
Last updated
2026-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary fracture fixation surgery Surgery

Interventions

Current interventions as of 11/02/2026: This is a multi-centre feasibility RCT recruiting ankle fracture patients from University Hospitals Coventry and Warwickshire and Royal London Hospital with an

Sponsors

University of Warwick
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Feasibility RCT: 1. Aged 18 years and over 2. Patients undergoing primary fracture fixation surgery for a closed ankle fracture within 2 weeks of date of injury under general and/or regional anaesthetic 3. Capacity to give informed consent Embedded Qualitative Interview Study: 1. Aged 18 years and over 2.1. Consultant Trauma & Orthopaedic Surgeons who participated or declined to participate in the feasibility randomised controlled trial OR 2.2. Patients who participated or declined to participate in the feasibility randomised controlled trial 3. Ability to provide informed consent

Exclusion criteria

Exclusion criteria: Feasibility RCT: 1. Patients with a pilon fracture 2. Unable to understand and speak English (or does not have relative willing to translate) 3. Patients with a chronic musculoskeletal or neurological condition (excluding diabetes mellitus) affecting the operative limb, or a history of prior surgery on the affected limb Embedded Qualitative Interview Study: 1. Unable to understand and speak English (or does not have relative willing to translate)

Design outcomes

Primary

MeasureTime frame
1. Recruitment rates measured throughout the recruitment period using a study site tracker 2. Retention rates will be assessed at the end of the study by comparing the number of participants recruited and those who have completed the study 3. Data completeness will be assessed periodically using reports from the database 4. Blinding feasibility will be assessed based on reports of unblinding (up to 3 months post patient ankle fracture fixation) and explored during the surgeon qualitative interviews 5. Intervention adherence will be measured throughout the study recruitment and follow-up period, based on reported protocol deviations/violations

Secondary

MeasureTime frame
1. Post-operative pain measured at baseline, 24 hours, 3 weeks and 3 months post-operatively using the painDETECT questionnaire and 11-point pain Numerical Rating Scale 2. Surgical field of view measured on the day of the procedure using a 5-point Likert scale 3. Blood loss and blood transfusions measured on the day of the procedure and up to 2 weeks post-procedure by measuring the weight of the surgical swabs, volume of blood collected and number of intraoperative and post-operative blood transfusions 4. Length of procedure measured on the day of the procedure 5. Skin assessment will be assessed pre-operatively and on the day of the procedure and collected from medical notes 6. Awareness of tourniquet use will be measured post-operatively using a self-completed questionnaire 7. Health-related quality of life will be measured at baseline, 3 weeks and 3 months post-operatively using a modified EQ5D5L questionnaire 8. Functional recovery after the ankle injury will be assessed using the Olerud-Molander Ankle Score at baseline, 3 weeks and 3 months post-operatively 9. Post-operative complications measured 3 months post-procedure will be captured using a patient self-reported questionnaire 10. Intra-operative complications will be captured on the day of the procedure through a surgeon-completed questionnaire

Countries

England, United Kingdom

Contacts

Public ContactCristiana Huhulea
cristiana.huhulea@uhcw.nhs.uk+44 (0)24 7696 7476

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: May 30, 2026